Silence Therapeutics reported 16.91M in Current Liabilities for its fiscal quarter ending in September of 2024.


Current Liabilities Change Date
AstraZeneca USD 33.54B 4.41B Jun/2025
Autolus Therapeutics Ltd 68.15M 1.54M Jun/2025
Hikma Pharmaceutical USD 1.98B 598M Dec/2024
Novartis USD 31.71B 95M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Silence Therapeutics 16.91M 1.03M Sep/2024